Common variants associated with plasma triglycerides and risk for coronary artery disease
(263)
Do, Ron
a,b,c
Willer, Cristen J
d,e
Schmidt, Ellen M
e
Sengupta, Sebanti
e
Gao, Chi
a,c
Peloso, Gina M
a,c,f
Gustafsson, Stefan
g
Kanoni, Stavroula
h
Ganna, Andrea
g,i
Chen, Jin
e
Buchkovich, Martin L
j
Mora, Samia
k
Beckmann, Jacques S
l,m
Bragg Gresham, Jennifer L
e
Chang, Hsing Yi
n
Demirkan, Ayse
o
Den Hertog, Heleen M
o
Donnelly, Louise A
p
Ehret, Georg B
q,r
Esko, Tõnu
c,s,t
Feitosa, Mary F
u
Ferreira, Teresa
v
Fischer, Krista
s
Fontanillas, Pierre
c
Fraser, Ross M
w
Freitag, Daniel F
x
Gurdasani, Deepti
h,x
Heikkilä, Kauko
y
Hyppönen, Elina
z
Isaacs, Aaron
o,aa
Jackson, Anne U
e
Johansson, Åsa
g
Johnson, Toby
ab
Kaakinen, Marika
ac
Kettunen, Johannes
y,ad
Kleber, Marcus E
ae,af
Li, Xiaohui
ag
Luan, Jian'an
ah
Lyytikäinen, Leo Pekka
ai,aj
Magnusson, Patrik K E
i
Mangino, Massimo
ak
Mihailov, Evelin
s,t
Montasser, May E
al
Müller Nurasyid, Martina
am,an,ao
Nolte, Ilja M
ap
O'Connell, Jeffrey R
al
Palmer, Cameron D
c,aq
Perola, Markus
s,y,ad
Petersen, Ann Kristin
am
Sanna, Serena
ar
Saxena, Richa
a
Service, Susan K
as
Shah, Sonia
at
Shungin, Dmitry
au,av,aw
Sidore, Carlo
e,ar,ax
Song, Ci
g,i
Strawbridge, Rona J
ay
Surakka, Ida
y,ad
Tanaka, Toshiko
az
Teslovich, Tanya M
e
Thorleifsson, Gudmar
ba
Van Den Herik, Evita G
o
Voight, Benjamin F
bb
Volcik, Kelly A
bc
Waite, Lindsay L
bd
Wong, Andrew
be
Wu, Ying
j
Zhang, Weihua
bf,bg
Absher, Devin
bd
Asiki, Gershim
bh
Barroso, Inês
h,x,ah
Been, Latonya F
bi
Bolton, Jennifer L
w
Bonnycastle, Lori L
bj
Brambilla, Paolo
bk
Burnett, Mary S
bl
Cesana, Giancarlo
bk
Dimitriou, Maria
bm
Doney, Alex S F
p
Döring, Angela
am
Elliott, Paul
ac,bf
Epstein, Stephen E
bl
Eyjolfsson, Gudmundur Ingi
bn
Gigante, Bruna
i
Goodarzi, Mark O
ag
Grallert, Harald
am
Gravito, Martha L
bi
Groves, Christopher J
bo
Hallmans, Göran
av
Hartikainen, Anna Liisa
bp
Hayward, Caroline
bq
Hernandez, Dena
br
Hicks, Andrew A
bs
Holm, Hilma
ba
Hung, Yi Jen
bt
Illig, Thomas
am,bu
Jones, Michelle R
ag
Kaleebu, Pontiano
bh
Kastelein, John J P
bv
Khaw, Kay Tee
x
Kim, Eric
ag
Klopp, Norman
am,bu
Komulainen, Pirjo
bw
Kumari, Meena
at
Langenberg, Claudia
ah
Lehtimäki, Terho
ai,aj
Lin, Shih Yi
bx
Lindström, Jaana
ad
Loos, Ruth J F
ah,by
Mach, François
q
McArdle, Wendy L
bz
Meisinger, Christa
am
Mitchell, Braxton D
al
Müller, Gabrielle
ca
Nagaraja, Ramaiah
br
Narisu, Narisu
bj
Nieminen, Tuomo V M
aj,cb,cc
Nsubuga, Rebecca N
bh
Olafsson, Isleifur
cd
Ong, Ken K
ah,be
Palotie, Aarno
h,y,cc
Papamarkou, Theodore
h,x,at
Pomilla, Cristina
h,x
Pouta, Anneli
ad,bp
Rader, Daniel J
bb
Reilly, Muredach P
bb
Ridker, Paul M
k
Rivadeneira, Fernando
o,ce
Rudan, Igor
w
Ruokonen, Aimo
ac
Samani, Nilesh
cf,cg
Scharnagl, Hubert
ch
Seeley, Janet
bh,ci
Silander, Kaisa
y,ad
Stancáková, Alena
bw
Stirrups, Kathleen
h
Swift, Amy J
bj
Tiret, Laurence
cj
Uitterlinden, Andre G
o,ce
Van Pelt, L Joost
ap
Vedantam, Sailaja
c,aq
Wainwright, Nicholas
h,x
Wijmenga, Cisca
ap
Wild, Sarah H
w
Willemsen, Gonneke
ck
Wilsgaard, Tom
cl
Wilson, James F
w
Young, Elizabeth H
h,x
Zhao, Jing Hua
ah
Adair, Linda S
cm
Arveiler, Dominique
cn
Assimes, Themistocles L
co
Bandinelli, Stefania
cp
Bennett, Franklyn
cq
Bochud, Murielle
cr
Boehm, Bernhard O
ae,cs
Boomsma, Dorret I
ck
Borecki, Ingrid B
u
Bornstein, Stefan R
ca
Bovet, Pascal
cr,ct
Burnier, Michel
l
Campbell, Harry
w
Chakravarti, Aravinda
r
Chambers, John C
bf,bg,cu
Chen, Yii Der Ida
ag,cv
Collins, Francis S
bj
Cooper, Richard S
cw
Danesh, John
x
Dedoussis, George
bm
De Faire, Ulf
i
Feranil, Alan B
cx
Ferrières, Jean
cy
Ferrucci, Luigi
az
Freimer, Nelson B
as,cv
Gieger, Christian
am
Groop, Leif C
cc,cz
Gudnason, Vilmundur
da
Gyllensten, Ulf
g
Hamsten, Anders
ay
Harris, Tamara B
db
Hingorani, Aroon
at
Hirschhorn, Joel N
c,aq
Hofman, Albert
o,ce
Hovingh, G Kees
bv
Hsiung, Chao Agnes
n
Humphries, Steve E
at
Hunt, Steven C
dc
Hveem, Kristian
dd
Iribarren, Carlos
de
Järvelin, Marjo Riitta
ac,ad,bf,bp
Jula, Antti
ad
Kähönen, Mika
aj
Kaprio, Jaakko
y,ad
Kesäniemi, Antero
ac
Kivimaki, Mika
at
Kooner, Jaspal S
bg,cu,df
Koudstaal, Peter J
o
Krauss, Ronald M
dg
Kuh, Diana
be
Kuusisto, Johanna
bw
Kyvik, Kirsten O
dh,di
Laakso, Markku
bw
Lakka, Timo A
bw
Lind, Lars
g
Lindgren, Cecilia M
v
Martin, Nicholas G
dj
März, Winfried
af,ch,dk
McCarthy, Mark I
v,bo
McKenzie, Colin A
dl
Meneton, Pierre
dm
Metspalu, Andres
s,t
Moilanen, Leena
dn
Morris, Andrew D
p
Munroe, Patricia B
ab
Njølstad, Inger
cl
Pedersen, Nancy L
i
Power, Chris
z
Pramstaller, Peter P
bs,do,dp
Price, Jackie F
w
Psaty, Bruce M
dq,dr
Quertermous, Thomas
co
Rauramaa, Rainer
bw,dn
Saleheen, Danish
x,ds,dt
Salomaa, Veikko
ad
Sanghera, Dharambir K
bi
Saramies, Jouko
du
Schwarz, Peter E H
ca,dv
Sheu, Wayne H H
dw
Shuldiner, Alan R
al,dx
Siegbahn, Agneta
g
Spector, Tim D
ak
Stefansson, Kari
ba,dy
Strachan, David P
dz
Tayo, Bamidele O
cw
Tremoli, Elena
ea
Tuomilehto, Jaakko
ad,eb,ec,ed
Uusitupa, Matti
bw,dn
Van Duijn, Cornelia M
o,aa
Vollenweider, Peter
l
Wallentin, Lars
g
Wareham, Nicholas J
ah
Whitfield, John B
dj
Wolffenbuttel, Bruce H R
ap
Altshuler, David
a,b,c
Ordovas, Jose M
ee,ef,eg
Boerwinkle, Eric
bc
Palmer, Colin N A
p
Thorsteinsdottir, Unnur
ba,dy
Chasman, Daniel I
k
Rotter, Jerome I
ag
Franks, Paul W
au,aw,eh
Ripatti, Samuli
h,y,ad
Cupples, L Adrienne
f,ei
Sandhu, Manjinder S
h,x
Rich, Stephen S
ej
Boehnke, Michael
e
Deloukas, Panos
h
Mohlke, Karen L
j
Ingelsson, Erik
g,v
Abecasis, Goncalo R
e
Daly, Mark J
a,c
Neale, Benjamin M
a,c,ej
Kathiresan, Sekar
a,b,c
more..
|
-
1
-
-
0030996001
-
Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study
-
Murray, C.J. & Lopez, A.D. Global mortality, disability, and the contribution of risk factors: Global Burden of Disease Study. Lancet 349, 1436-1442 (1997
-
(1997)
Lancet
, vol.349
, pp. 1436-1442
-
-
Murray, C.J.1
Lopez, A.D.2
-
2
-
-
70450081001
-
Major lipids, apolipoproteins, and risk of vascular disease
-
Di Angelantonio, E. et al. Major lipids, apolipoproteins, and risk of vascular disease. J. Am. Med. Assoc. 302, 1993-2000 (2009
-
(2009)
J. Am. Med. Assoc
, vol.302
, pp. 1993-2000
-
-
Di Angelantonio, E.1
-
3
-
-
33846637379
-
Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies
-
Sarwar, N. et al. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 115, 450-458 (2007
-
(2007)
Circulation
, vol.115
, pp. 450-458
-
-
Sarwar, N.1
-
4
-
-
50949084462
-
Mendelian randomisation and causal inference in observational epidemiology
-
Sheehan, N.A., Didelez, V., Burton, P.R. & Tobin, M.D. Mendelian randomisation and causal inference in observational epidemiology. PLoS Med. 5, e177 (2008
-
(2008)
PLoS Med
, vol.5
-
-
Sheehan, N.A.1
Didelez, V.2
Burton, P.R.3
Tobin, M.D.4
-
5
-
-
0037322022
-
Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease?
-
Smith, G.D. & Ebrahim, S. 'Mendelian randomization': Can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 32, 1-22 (2003
-
(2003)
Int. J. Epidemiol
, vol.32
, pp. 1-22
-
-
Smith, G.D.1
Ebrahim, S.2
-
6
-
-
38949127024
-
Mendelian randomization: Can genetic epidemiology help redress the failures of observational epidemiology?
-
Ebrahim, S. & Davey Smith, G. Mendelian randomization: Can genetic epidemiology help redress the failures of observational epidemiology? Hum. Genet. 123, 15-33 (2008
-
(2008)
Hum. Genet
, vol.123
, pp. 15-33
-
-
Ebrahim, S.1
Davey Smith, G.2
-
7
-
-
38049023073
-
Clustered environments and randomized genes: A fundamental distinction between conventional and genetic epidemiology
-
Smith, G.D. et al. Clustered environments and randomized genes: A fundamental distinction between conventional and genetic epidemiology. PLoS Med. 4, e352 (2007
-
(2007)
PLoS Med
, vol.4
-
-
Smith, G.D.1
-
8
-
-
1942436221
-
Mendelian randomization: Prospects, potentials, and limitations
-
Smith, G.D. & Ebrahim, S. Mendelian randomization: Prospects, potentials, and limitations. Int. J. Epidemiol. 33, 30-42 (2004
-
(2004)
Int. J. Epidemiol
, vol.33
, pp. 30-42
-
-
Smith, G.D.1
Ebrahim, S.2
-
9
-
-
33645103550
-
Sequence variations in PCSK9, low LDL, and protection against coronary heart disease
-
Cohen, J.C., Boerwinkle, E., Mosley, T.H. Jr. & Hobbs, H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N. Engl. J. Med. 354, 1264-1272 (2006
-
(2006)
N. Engl. J. Med
, vol.354
, pp. 1264-1272
-
-
Cohen, J.C.1
Boerwinkle, E.2
Mosley Jr., T.H.3
Hobbs, H.H.4
-
10
-
-
38649125868
-
Newly identified loci that influence lipid concentrations and risk of coronary artery disease
-
Willer, C.J. et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161-169 (2008
-
(2008)
Nat. Genet
, vol.40
, pp. 161-169
-
-
Willer, C.J.1
-
11
-
-
84864845456
-
Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study
-
Voight, B.F. et al. Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study. Lancet 380, 572-580 (2012
-
(2012)
Lancet
, vol.380
, pp. 572-580
-
-
Voight, B.F.1
-
12
-
-
84856786437
-
LCAT, HDL cholesterol and ischemic cardiovascular disease: A Mendelian randomization study of HDL cholesterol in 54,500 individuals
-
Haase, C.L. et al. LCAT, HDL cholesterol and ischemic cardiovascular disease: A Mendelian randomization study of HDL cholesterol in 54,500 individuals. J. Clin. Endocrinol. Metab. 97, E248-E256 (2012
-
(2012)
J. Clin. Endocrinol. Metab
, vol.97
-
-
Haase, C.L.1
-
13
-
-
78650052979
-
Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease
-
Haase, C.L., Tybjaerg-Hansen, A., Grande, P. & Frikke-Schmidt, R. Genetically elevated apolipoprotein A-I, high-density lipoprotein cholesterol levels, and risk of ischemic heart disease. J. Clin. Endocrinol. Metab. 95, E500-E510 (2010
-
(2010)
J. Clin. Endocrinol. Metab
, vol.95
-
-
Haase, C.L.1
Tybjaerg-Hansen, A.2
Grande, P.3
Frikke-Schmidt, R.4
-
14
-
-
44649140474
-
Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease
-
Frikke-Schmidt, R. et al. Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease. J. Am. Med. Assoc. 299, 2524-2532 (2008
-
(2008)
J. Am. Med. Assoc
, vol.299
, pp. 2524-2532
-
-
Frikke-Schmidt, R.1
-
15
-
-
65249148632
-
Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease
-
Johannsen, T.H. et al. Hepatic lipase, genetically elevated high-density lipoprotein, and risk of ischemic cardiovascular disease. J. Clin. Endocrinol. Metab. 94, 1264-1273 (2009
-
(2009)
J. Clin. Endocrinol. Metab
, vol.94
, pp. 1264-1273
-
-
Johannsen, T.H.1
-
16
-
-
58149163149
-
Common variants at 30 loci contribute to polygenic dyslipidemia
-
Kathiresan, S. et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56-65 (2009
-
(2009)
Nat. Genet
, vol.41
, pp. 56-65
-
-
Kathiresan, S.1
-
17
-
-
77955505564
-
Biological, clinical and population relevance of 95 loci for blood lipids
-
Teslovich, T.M. et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 (2010
-
(2010)
Nature
, vol.466
, pp. 707-713
-
-
Teslovich, T.M.1
-
18
-
-
77951875017
-
Triglyceride-mediated pathways and coronary disease: Collaborative analysis of 101 studies
-
Sarwar, N. et al. Triglyceride-mediated pathways and coronary disease: Collaborative analysis of 101 studies. Lancet 375, 1634-1639 (2010
-
(2010)
Lancet
, vol.375
, pp. 1634-1639
-
-
Sarwar, N.1
-
19
-
-
77952484063
-
Mendelian randomization as applied to coronary heart disease, including recent advances incorporating new technology
-
Lewis, S.J. Mendelian randomization as applied to coronary heart disease, including recent advances incorporating new technology. Circ Cardiovasc Genet 3, 109-117 (2010
-
(2010)
Circ Cardiovasc Genet
, vol.3
, pp. 109-117
-
-
Lewis, S.J.1
-
20
-
-
84887099827
-
Discovery and refinement of loci associated with lipid levels
-
Global Lipids Genetics Consortium. doi:10.1038/ng.2797 6 October
-
Global Lipids Genetics Consortium. Discovery and refinement of loci associated with lipid levels. Nat. Genet. doi:10.1038/ng.2797 (6 October 2013
-
(2013)
Nat. Genet
-
-
-
21
-
-
79953204259
-
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
-
Schunkert, H. et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338 (2011
-
(2011)
Nat. Genet
, vol.43
, pp. 333-338
-
-
Schunkert, H.1
-
22
-
-
0035812707
-
An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing
-
Pennacchio, L.A. et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169-173 (2001
-
(2001)
Science
, vol.294
, pp. 169-173
-
-
Pennacchio, L.A.1
-
23
-
-
38649132270
-
Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans
-
Kathiresan, S. et al. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40, 189-197 (2008
-
(2008)
Nat. Genet
, vol.40
, pp. 189-197
-
-
Kathiresan, S.1
-
24
-
-
58149262866
-
A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection
-
Pollin, T.I. et al. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Science 322, 1702-1705 (2008
-
(2008)
Science
, vol.322
, pp. 1702-1705
-
-
Pollin, T.I.1
-
25
-
-
84871969762
-
Large-scale association analysis identifies new risk loci for coronary artery disease
-
Deloukas, P. et al. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat. Genet. 45, 25-33 (2013
-
(2013)
Nat. Genet
, vol.45
, pp. 25-33
-
-
Deloukas, P.1
-
26
-
-
85027956925
-
Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association
-
Miller, M. et al. Triglycerides and cardiovascular disease: A scientific statement from the American Heart Association. Circulation 123, 2292-2333 (2011
-
(2011)
Circulation
, vol.123
, pp. 2292-2333
-
-
Miller, M.1
-
27
-
-
84872675457
-
Remnant cholesterol as a causal risk factor for ischemic heart disease
-
Varbo, A. et al. Remnant cholesterol as a causal risk factor for ischemic heart disease. J. Am. Coll. Cardiol. 61, 427-436 (2013
-
(2013)
J. Am. Coll. Cardiol
, vol.61
, pp. 427-436
-
-
Varbo, A.1
-
28
-
-
0032510639
-
Prediction of coronary heart disease using risk factor categories
-
Wilson, P.W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837-1847 (1998
-
(1998)
Circulation
, vol.97
, pp. 1837-1847
-
-
Wilson, P.W.1
-
29
-
-
84864219466
-
N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia
-
Bosch, J. et al. n-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N. Engl. J. Med. 367, 309-318 (2012
-
(2012)
N. Engl. J. Med
, vol.367
, pp. 309-318
-
-
Bosch, J.1
-
30
-
-
0033527030
-
Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol
-
Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group
-
Rubins, H.B. et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. N. Engl. J. Med. 341, 410-418 (1999
-
(1999)
N. Engl. J. Med
, vol.341
, pp. 410-418
-
-
Rubins, H.B.1
-
31
-
-
28044452217
-
Effects of long-Term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial
-
Keech, A. et al. Effects of long-Term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): Randomised controlled trial. Lancet 366, 1849-1861 (2005
-
(2005)
Lancet
, vol.366
, pp. 1849-1861
-
-
Keech, A.1
-
32
-
-
77951704587
-
Effects of combination lipid therapy in type 2 diabetes mellitus
-
Ginsberg, H.N. et al. Effects of combination lipid therapy in type 2 diabetes mellitus. N. Engl. J. Med. 362, 1563-1574 (2010
-
(2010)
N. Engl. J. Med
, vol.362
, pp. 1563-1574
-
-
Ginsberg, H.N.1
-
33
-
-
84975742565
-
A map of human genome variation from population-scale sequencing
-
1000 Genomes Project Consortium
-
1000 Genomes Project Consortium. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010
-
(2010)
Nature
, vol.467
, pp. 1061-1073
-
-
-
34
-
-
84952094529
-
Detection of influential observations in linear regression
-
Cook, R.D. Detection of influential observations in linear regression. Technometrics 19, 15-18 (1977
-
(1977)
Technometrics
, vol.19
, pp. 15-18
-
-
Cook, R.D.1
|